Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 CYTHW:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/30/22 EDT
0.50UNCH (UNCH)
52 week range
0.50 - 5.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.50
  • 52 Week High5.50
  • 52 Week High Date07/01/21
  • 52 Week Low0.50
  • 52 Week Low Date06/30/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.50
  • 52 Week High5.50
  • 52 Week High Date07/01/21
  • 52 Week Low0.50
  • 52 Week Low Date06/30/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's...
Address
6714 Nw 16Th Street,, Suite B
Gainesville, FL
32653
United States